KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,798 | -11.4% | 1,952 | -17.2% | 0.00% | – |
| Q2 2023 | $21,213 | +14.5% | 2,357 | 0.0% | 0.00% | – |
| Q1 2023 | $18,526 | +16.3% | 2,357 | 0.0% | 0.00% | – |
| Q4 2022 | $15,933 | -53.1% | 2,357 | 0.0% | 0.00% | – |
| Q3 2022 | $34,000 | +70.0% | 2,357 | +14.8% | 0.00% | – |
| Q2 2022 | $20,000 | -50.0% | 2,053 | -26.0% | 0.00% | – |
| Q1 2022 | $40,000 | +8.1% | 2,773 | 0.0% | 0.00% | – |
| Q4 2021 | $37,000 | -11.9% | 2,773 | +13.1% | 0.00% | – |
| Q3 2021 | $42,000 | -28.8% | 2,452 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | +37.2% | 2,452 | +47.2% | 0.00% | – |
| Q1 2021 | $43,000 | +72.0% | 1,666 | +26.4% | 0.00% | – |
| Q4 2020 | $25,000 | +47.1% | 1,318 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -19.0% | 1,318 | -24.1% | 0.00% | – |
| Q2 2020 | $21,000 | +31.2% | 1,736 | -17.3% | 0.00% | – |
| Q1 2020 | $16,000 | -60.0% | 2,099 | -13.3% | 0.00% | – |
| Q4 2019 | $40,000 | +73.9% | 2,422 | +24.6% | 0.00% | – |
| Q3 2019 | $23,000 | -46.5% | 1,944 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | – | 1,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |